Yarahmadi S - Search Results

1

Evaluating the local expression pattern of IGF-1R in tumor tissues and the circulating levels of IGF-1, IGFBP-1, and IGFBP-3 in the blood of patients with different primary bone tumors.

Vaezi MA, Eghtedari AR, Safizadeh B, Babaheidarian P, Salimi V, Adjaminezhad-Fard F, Yarahmadi S, Mirzaei A, Rahbar M, Tavakoli-Yaraki M. Vaezi MA, et al. Among authors: yarahmadi s. Front Oncol. 2023 Jan 13;12:1096438. doi: 10.3389/fonc.2022.1096438. eCollection 2022. Front Oncol. 2023. PMID: 36713521 Free PMC article.

2

Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells.

Hesari Z, Nourbakhsh M, Hosseinkhani S, Abdolvahabi Z, Alipour M, Tavakoli-Yaraki M, Ghorbanhosseini SS, Yousefi Z, Jafarzadeh M, Yarahmadi S. Hesari Z, et al. Among authors: yarahmadi s. Gene. 2018 Oct 5;673:149-158. doi: 10.1016/j.gene.2018.06.021. Epub 2018 Jun 8. Gene. 2018. PMID: 29886033

3

Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells.

Yarahmadi S, Abdolvahabi Z, Hesari Z, Tavakoli-Yaraki M, Yousefi Z, Seiri P, Hosseinkhani S, Nourbakhsh M. Yarahmadi S, et al. Gene. 2019 Aug 30;711:143939. doi: 10.1016/j.gene.2019.06.029. Epub 2019 Jun 18. Gene. 2019. PMID: 31220581

4

Hesperetin attenuates the expression of markers of adipose tissue fibrosis in pre-adipocytes.

Taheri A, Mobaser SE, Golpour P, Nourbakhsh M, Tavakoli-Yaraki M, Yarahmadi S, Nourbakhsh M. Taheri A, et al. Among authors: yarahmadi s. BMC Complement Med Ther. 2023 Sep 11;23(1):315. doi: 10.1186/s12906-023-04152-z. BMC Complement Med Ther. 2023. PMID: 37697354 Free PMC article.

5

Circulating Levels of C1q/TNF-Related Protein 3 (CTRP3) and CTRP9 in Gestational Diabetes and Their Association with Insulin Resistance and Inflammatory Cytokines.

Fadaei R, Goodarzi G, Yarahmadi S, Allahyari P, Fallah S, Moradi N. Fadaei R, et al. Among authors: yarahmadi s. Lab Med. 2023 May 2;54(3):262-269. doi: 10.1093/labmed/lmac096. Lab Med. 2023. PMID: 36219707

6

Therapeutic Potential of Resveratrol and Atorvastatin Following High-Fat Diet Uptake-Induced Nonalcoholic Fatty Liver Disease by Targeting Genes Involved in Cholesterol Metabolism and miR33.

Yarahmadi S, Farahmandian N, Fadaei R, Koushki M, Bahreini E, Karima S, Barzin Tond S, Rezaei A, Nourbakhsh M, Fallah S. Yarahmadi S, et al. DNA Cell Biol. 2023 Feb;42(2):82-90. doi: 10.1089/dna.2022.0581. Epub 2023 Feb 1. DNA Cell Biol. 2023. PMID: 36730721

7

Adipose triglyceride lipase gene expression in peripheral blood mononuclear cells of subjects with obesity and its association with insulin resistance, inflammation and lipid accumulation in liver.

Ezzati-Mobaser S, Yarahmadi S, Dadkhah Nikroo N, Maleki MH, Yousefi Z, Golpour P, Nourbakhsh M, Nourbakhsh M. Ezzati-Mobaser S, et al. Among authors: yarahmadi s. Obes Sci Pract. 2023 Oct 25;10(1):e716. doi: 10.1002/osp4.716. eCollection 2024 Feb. Obes Sci Pract. 2023. PMID: 38263987 Free PMC article.

8

Captopril and Spironolactone can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting ABCA1 and microRNA-33.

Ghaffari T, Moradi N, Chamani E, Ebadi Z, Fadaei R, Alizadeh-Fanalou S, Yarahmadi S, Fallah S. Ghaffari T, et al. Among authors: yarahmadi s. Curr Pharm Des. 2022;28(16):1367-1372. doi: 10.2174/1381612828666220401143249. Curr Pharm Des. 2022. PMID: 35366766

9

MicroRNA-590-3P suppresses cell survival and triggers breast cancer cell apoptosis via targeting sirtuin-1 and deacetylation of p53.

Abdolvahabi Z, Nourbakhsh M, Hosseinkhani S, Hesari Z, Alipour M, Jafarzadeh M, Ghorbanhosseini SS, Seiri P, Yousefi Z, Yarahmadi S, Golpour P. Abdolvahabi Z, et al. Among authors: yarahmadi s. J Cell Biochem. 2019 Jun;120(6):9356-9368. doi: 10.1002/jcb.28211. Epub 2018 Dec 5. J Cell Biochem. 2019. PMID: 30520099

10

Investigation of the effects of catharanthine and Q10 on Nrf2 and its association with MMP-9, MRP1, and Bcl-2 and apoptosis in a model of hepatocellular carcinoma.

Heidari-Kalvani N, Alizadeh-Fanalou S, Yarahmadi S, Fallah S, Alipourfard I, Farahmandian N, Barjesteh F, Bahreini E. Heidari-Kalvani N, et al. Among authors: yarahmadi s. Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr;397(4):2507-2522. doi: 10.1007/s00210-023-02767-0. Epub 2023 Oct 19. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37855932

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page